Plus LibraryBy pinki@katapult.biz / February 13, 2025 Speciality — Amyotrophic Lateral Sclerosis (ALS) Biomarkers Biosimilars Bladder Blood Bone Brain Breast Cancer Central Nervous System (CNS) Clinical Trials Colon Colorectal Diversity, Equity & Inclusion Featured Content Gastrointestinal Genitourinary Genomic Geriatric Gynecology Head and Neck Hematologic Hematologic Maglinencies Hematology Immunotherapy Interventional Radiology Kidney Leukemia Liquid Biopsy Liver Lung Lymphoma Malignencies Melanoma Myelodysplastic Syndrome Myeloma Neuroendocrine Novel Oral & Maxillofacial Surgery Ovarian Pancreas Pancreatic Pharmacological Prostate Radiation Radiology Renal Sarcoma Skin Solid Tumor Supportive & Palliative Care Survivorship Telemedicine Thoracic Thrombosis Thymic Thyroid Urothelial Author / Speaker Title of Presentation Type of Media — Video Document Audio Event 2024 Event — 2024 California Cancer Consortium Conference (CCC) 2024 MLS Cleveland 2024 MLS Nashville 2024 MLS New Orleans 2024 MLS Seattle 2024 New Orleans Summer Cancer Meeting (NOSCM) 2024 PRIMO 2024 SPS Puerto Rico 2024 SPS Seattle 2024 SPECTRUM 2024 Sylvester APP Oncology Symposium 2024 WCS 2024 MaTOS Lungs 2025 PRIMO Clear Displaying 1,576 - 1,600 of 2,875 « 1 … 62 63 64 65 66 … 115 » EGFR and Resistant Mechanisms Edgardo S. Santos, MD, FACP, FASCO View PDF Master Lecture on Targeting NSCLCDriver Pathways Edgardo S. Santos, MD, FACP, FASCO View PDF Updated Management on Advanced NSCLC Driver Mutant Tumors Edgardo S. Santos, MD, FACP, FASCO View PDF Lung Cancer Session Edgardo S. Santos, MD, FACP, Janakiraman Subramanian, MD, MPH,Luis E Raez, MD, FACP, FCCP, Mark A. Socinski, MD, View Video Dealing with EGFRex19del & L858R, ALK, and K-RasG12C Genetic Aberrations Edgardo Santos, MD View PDF Non-Small Cell Lung Cancer: EGFR, ALK, & K-Ras Pathways Edgardo Santos, MD, FACP View PDF Targeted Therapy in Non-Squamous NSCLC: Where Are We and What is Coming Up Edgardo Santos, MD, FACP View Video EGFR and Resistant Mechanisms Edgardo Santos, MD, FACP View PDF EGFR and Resistant Mechanisms Edgardo Santos, MD, FACP View Video Small Cell Lung Cancer Erin Schenk, MD, PhD View PDF Small Cell Lung Cancer Erin Schenk, MD, PhD View Video Immunotherapy Toxicities and Lung Biomarkers Erin Schenk, MD, PhD View PDF Immunotherapy Toxicities and Lung Biomarkers Erin Schenk, MD, PhD View Video Updates in Treatment of Early Stage and Locally Advanced NSCLC Erminia Massarelli, MD, PhD, MS View PDF Updates in Treatment of Early Stage and Locally Advanced NSCLC Erminia Massarelli, MD, PhD, MS View Video Updates in Treatment of Early Stage and Locally Advanced NSCLC Erminia Massarelli, MD, PhD, MS View PDF Updates in Treatment of Early Stage and Locally Advanced NSCLC Erminia Massarelli, MD, PhD, MS View Video KRAS and EGFR Exon 20 Insertion Erminia Massarelli, MD, PhD, MS View PDF Other Driver Mutations: ROS-1, BRAF, MET and RET Erminia Massarelli, MD, PhD, MS View PDF Updates in Immunotherapy for Metastatic Lung Cancer Erminia Massarelli, MD, PhD, MS View PDF Other Driver Mutations: ROS-1, BRAF, MET and RET Erminia Massarelli, MD, PhD, MS View Video Updates in Immunotherapy for Metastatic Lung Cancer Erminia Massarelli, MD, PhD, MS View Video ERBB2 and NGR1 Pathways in NSCLC Estelamari Rodriguez, MD View PDF ERBB2 and NGR1 Pathways in NSCLC Estelamari Rodriguez, MD View Video The Role of Co-Mutations with Immunotherapy Response in NSCLC Ferdinando Skoulidis, MD View PDF
